You are an early-stage venture capitalist conducting due diligence on a biotech start-up. You are willing to contribute $1,500,000 in the first round of financing, and you target a final exit multiple of 12 invested capital, which estimate will happen in ten years. At that time, you estimate the firm will sell for $80,000,000. You expect an additional round of financing in four years in which you will not participate that will dilute your ownership share by 40%. What final equity position (weight) must you require for your investment? Multiple Choice 76.79% 50.00% 15.40% 1.80% 37.50%